Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial.

ABSTRACT:

SUBMITTER: Lamarca A 

PROVIDER: S-EPMC8082275 | biostudies-literature | 2021 May

REPOSITORIES: biostudies-literature